Weidong Hu

3.0k total citations · 1 hit paper
44 papers, 1.9k citations indexed

About

Weidong Hu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weidong Hu has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Molecular Biology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weidong Hu's work include Lung Cancer Treatments and Mutations (8 papers), Ferroptosis and cancer prognosis (7 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Weidong Hu is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Ferroptosis and cancer prognosis (7 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Weidong Hu collaborates with scholars based in China, United States and Vietnam. Weidong Hu's co-authors include Sufang Tian, Li Niu, Huan Liu, Shu‐Yuan Xiao, Haibo Xu, Wenhui Zhou, Lu Lv, Sheng Li, Yujin Wang and Congkuan Song and has published in prestigious journals such as PLoS ONE, Cancer and Journal of Cellular Physiology.

In The Last Decade

Weidong Hu

43 papers receiving 1.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer

2020 989 citations Sufang Tian, Weidong Hu et al. Journal of Thoracic Oncology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Weidong Hu	723	538	472	451	360	44	1.9k
Ying-Nan Wang	866 1.2×	464 0.9×	223 0.5×	505 1.1×	447 1.2×	6	1.8k
Furong Zeng	538 0.7×	672 1.2×	532 1.1×	359 0.8×	412 1.1×	69	1.9k
Guangtong Deng	532 0.7×	607 1.1×	541 1.1×	357 0.8×	364 1.0×	67	1.8k
Jiong Yu	837 1.2×	618 1.1×	215 0.5×	278 0.6×	242 0.7×	76	2.2k
Yan Ding	447 0.6×	409 0.8×	126 0.3×	273 0.6×	193 0.5×	58	1.4k
Jing Yu	315 0.4×	501 0.9×	363 0.8×	883 2.0×	257 0.7×	61	1.7k
Da Xu	300 0.4×	839 1.6×	401 0.8×	609 1.4×	592 1.6×	71	2.1k
Sufang Tian	1.3k 1.7×	228 0.4×	380 0.8×	357 0.8×	66 0.2×	41	2.0k
Jing Cao	318 0.4×	516 1.0×	140 0.3×	221 0.5×	339 0.9×	67	1.2k

Countries citing papers authored by Weidong Hu

Since Specialization

Citations

This map shows the geographic impact of Weidong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weidong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weidong Hu more than expected).

Fields of papers citing papers by Weidong Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weidong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weidong Hu. The network helps show where Weidong Hu may publish in the future.

Co-authorship network of co-authors of Weidong Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Weidong Hu. A scholar is included among the top collaborators of Weidong Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weidong Hu. Weidong Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Dong, Daoquan Liu, Xianguo Wang, et al.. (2024). Advantages of robot-assisted resection of large mediastinal tumors: a single-center preliminary study. Journal of Robotic Surgery. 18(1). 190–190. 1 indexed citations

Hu, Liwen, et al.. (2023). Synchronous pulmonary MALT lymphoma and squamous cell lung cancer: a case report. World Journal of Surgical Oncology. 21(1). 182–182. 1 indexed citations

Song, Congkuan, Zhi-Quan Wu, Qingwen Wang, et al.. (2021). A Combined Two-mRNA Signature Associated With PD-L1 and Tumor Mutational Burden for Prognosis of Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9. 634697–634697. 12 indexed citations

Tian, Sufang, Weidong Hu, Li Niu, et al.. (2020). Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. Journal of Thoracic Oncology. 15(5). 700–704. 989 indexed citations breakdown →

Huang, Jingyu, Aifen Wang, Ganjun Kang, Dejia Li, & Weidong Hu. (2020). Clinical course of patients infected with severe acute respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery. Journal of Thoracic and Cardiovascular Surgery. 160(2). e91–e93. 6 indexed citations

Ruan, Xiaolan, Xiaoping Liu, Haoli Ma, et al.. (2020). Analysis of the Interaction Network of Hub miRNAs-Hub Genes, Being Involved in Idiopathic Pulmonary Fibers and Its Emerging Role in Non-small Cell Lung Cancer. Frontiers in Genetics. 11. 302–302. 34 indexed citations

Yu, Donghu, Xiaolan Ruan, Weidong Hu, et al.. (2020). Comprehensive Analysis of Competitive Endogenous RNAs Network, Being Associated With Esophageal Squamous Cell Carcinoma and Its Emerging Role in Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology. 9. 1474–1474. 15 indexed citations

Song, Congkuan, Donghu Yu, Yujin Wang, et al.. (2020). Dual Primary Cancer Patients With Lung Cancer as a Second Primary Malignancy: A Population-Based Study. Frontiers in Oncology. 10. 515606–515606. 15 indexed citations

Song, Congkuan, Zixin Guo, Donghu Yu, et al.. (2020). A Prognostic Nomogram Combining Immune-Related Gene Signature and Clinical Factors Predicts Survival in Patients With Lung Adenocarcinoma. Frontiers in Oncology. 10. 1300–1300. 64 indexed citations

10.

Guo, Zixin, Jingyu Huang, Yujin Wang, et al.. (2020). Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma. Frontiers in Genetics. 11. 547–547. 21 indexed citations

11.

Song, Congkuan, Hongyun Gong, Peter Liu, et al.. (2020). An online tool for predicting the prognosis of cancer patients with SARS-CoV-2 infection: a multi-center study. Journal of Cancer Research and Clinical Oncology. 147(4). 1247–1257. 8 indexed citations

12.

Wang, Yujin, Weidong Hu, Sheng Li, et al.. (2019). Clinical epidemiological analysis of 2 403 cases of lung cancer.. 46(8). 460–465. 1 indexed citations

13.

Cao, Yiyuan, et al.. (2017). Diagnostic accuracy of computed tomography imaging for the detection of differences between peripheral small cell lung cancer and peripheral non-small cell lung cancer. International Journal of Clinical Oncology. 22(5). 865–871. 10 indexed citations

14.

Lv, Lu, et al.. (2017). Association between CXCL16/CXCR6 expression and the clinicopathological features of patients with non-small cell lung cancer. Oncology Letters. 13(6). 4661–4668. 16 indexed citations

15.

Lv, Lu, et al.. (2016). Minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a meta-analysis. OncoTargets and Therapy. Volume 9. 6751–6762. 62 indexed citations

16.

Tu, Zhenbo, Songping Xie, Meng Xiong, et al.. (2016). CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer. International Journal of Oncology. 50(2). 505–514. 32 indexed citations

17.

Pan, Jingyu, Feng Zhang, Cheng‐Cao Sun, et al.. (2016). miR-134: A Human Cancer Suppressor?. Molecular Therapy — Nucleic Acids. 6. 140–149. 97 indexed citations

18.

Hu, Weidong, et al.. (2014). Effect of Cytoreductive Surgery Combined with Intraoperative Intra-Thoracic Hyperthermic Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer. 2(1). 1–5. 2 indexed citations

19.

Deng, Xinzhou, Yi Hu, Qianshan Ding, et al.. (2014). PEG10 plays a crucial role in human lung cancer proliferation, progression, prognosis and metastasis. Oncology Reports. 32(5). 2159–2167. 32 indexed citations

20.

Hu, Weidong, et al.. (2008). CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells. Cancer Science. 99(7). 1362–1369. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact